Related Experiment Video
Updated: Jun 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk
Yijia Sun1, Timothy Simmons2, James L Li1,3
1Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
Polygenic risk scores (PRSs) show promise for breast cancer (BC) risk stratification in African American women. A specific 162-variant PRS demonstrated high accuracy for triple-negative breast cancer (TNBC) risk assessment.
Area of Science:
- Genetics
- Oncology
- Epidemiology
Background:
- Validating polygenic risk scores (PRSs) is crucial for breast cancer (BC) risk stratification in high-risk populations.
- African-ancestry PRSs require evaluation in diverse cohorts for clinical utility.
Purpose of the Study:
- To assess the performance of African-ancestry PRSs for overall BC and triple-negative BC (TNBC) risk.
- To evaluate PRSs in an independent cohort of African American women with a high familial risk of BC.
Main Methods:
- A case-control study included 31,522 women of African ancestry undergoing genetic testing.
- Six African-ancestry PRSs and one European-ancestry PRS were evaluated.
- Performance was measured using area under the receiver operating characteristic curve (AUC) and odds ratios (OR).
Main Results:
- African-ancestry PRSs showed improved performance over European-ancestry PRS for overall BC.
- A 162-variant PRS demonstrated superior performance for TNBC, with an AUC of 0.609 and OR of 1.47.
- PRSs performed well in women with a strong family history of BC.
Conclusions:
- PRSs demonstrated good performance in African American women, particularly those with a strong family history of BC.
- The 162-variant TNBC PRS shows potential as a cost-effective tool for risk assessment.
- These findings support the use of PRSs to promote equitable breast cancer care.
Related Concept Videos
Cancer Survival Analysis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Polygenic Traits
Polygenic Traits
Principles of Pharmacogenetics: Types of Genetic Variants
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...